SEC Form 4 · accession 0000880771-17-000106
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hong Zhao
Officer — CEO, China Operations
Period of report
Jun 12, 2017
Accepted (ET)
Jun 14, 2017 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 12, 2017 | M | 12,500 | $0.00 | A | 12,500 | D | |
| Common Stock | Jun 12, 2017 | M | 25,000 | $0.00 | A | 37,500 | D | |
| Common Stock | Jun 12, 2017 | M | 3,000 | $0.00 | A | 40,500 | D | |
| Common Stock | Jun 12, 2017 | S | 3,000 | $10.75 | D | 37,500 | D | |
| Common Stock | Jun 12, 2017 | S | 12,500 | $10.75 | D | 25,000 | D | |
| Common Stock | Jun 12, 2017 | S | 25,000 | $10.75 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2,F3 | — | Jun 12, 2017 | M | 12,500 | D | — | — | Common Stock | 12,500 | 185,000 | D |
| Restricted Stock UnitF1,F2,F4 | — | Jun 12, 2017 | M | 25,000 | D | — | — | Common Stock | 25,000 | 160,000 | D |
| Restricted Stock UnitF1,F2,F5 | — | Jun 12, 2017 | M | 3,000 | D | — | — | Common Stock | 3,000 | 157,000 | D |
Explanation of responses
- F1Granted under the Issuer's 2005 Equity Incentive Plan.
- F2Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F3Provided Reporting Person remains employed by the Issuer, 25% of the restricted stock units will vest on each August 9, 2014, August 9, 2015, August 9, 2016, and August 9, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.
- F4Provided Reporting Person remains employed by the Issuer, 33.33% of the restricted stock units vested on January 4, 2016, 33.33% will vest on January 3,2017, and 33.34% will vest on January 2, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.
- F5Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.